120 STAT. 3526
PUBLIC LAW 109–469—DEC. 29, 2006
‘‘(c) RESEARCH AND DEVELOPMENT RESPONSIBILITIES.—The Director, acting through the Chief Scientist, shall— ‘‘(1) identify and define the short-, medium-, and longterm scientific and technological needs of Federal, State, local, and tribal drug supply reduction agencies, including— ‘‘(A) advanced surveillance, tracking, and radar imaging; ‘‘(B) electronic support measures; ‘‘(C) communications; ‘‘(D) data fusion, advanced computer systems, and artificial intelligence; and ‘‘(E) chemical, biological, radiological (including neutron and electron), and other means of detection; ‘‘(2) identify demand reduction basic and applied research needs and initiatives, in consultation with affected National Drug Control Program agencies, including— ‘‘(A) improving treatment through neuroscientific advances; ‘‘(B) improving the transfer of biomedical research to the clinical setting; and ‘‘(C) in consultation with the National Institute of Drug Abuse and the Substance Abuse and Mental Health Services Administration, and through interagency agreements or grants, examining addiction and rehabilitation research and the application of technology to expanding the effectiveness and availability of drug treatment; ‘‘(3) make a priority ranking of such needs identified in paragraphs (1) and (2) according to fiscal and technological feasibility, as part of a National Counterdrug Research and Development Program; ‘‘(4) oversee and coordinate counterdrug technology initiatives with related activities of other Federal civilian and military departments; ‘‘(5) provide support to the development and implementation of the national drug control performance measurement system established under subsection (c) of section 706; and ‘‘(6) pursuant to the authority of the Director of National Drug Control Policy under section 704, submit requests to Congress for the reprogramming or transfer of funds appropriated for counterdrug technology research and development. ‘‘(d) LIMITATION ON AUTHORITY.—The authority granted to the Director under this section shall not extend to the awarding of contracts, management of individual projects, or other operational activities.’’. (2) ASSISTANCE AND SUPPORT.—Subsection (e) of section 708, as redesignated by this section, is amended to read as follows: ‘‘(e) ASSISTANCE AND SUPPORT TO THE OFFICE OF NATIONAL DRUG CONTROL POLICY.—The Secretary of Defense, the Secretary of Homeland Security, and the Secretary of Health and Human Services shall, to the maximum extent practicable, render assistance and support to the Office and to the Director in the conduct of counterdrug technology assessment.’’. (3) TECHNOLOGY TRANSFER PROGRAM.—Section 708 is amended by adding at the end the following: ‘‘(f) TECHNOLOGY TRANSFER PROGRAM.—
VerDate 14-DEC-2004
12:05 Jul 13, 2007
Jkt 059194
PO 00003
Frm 00329
Fmt 6580
Sfmt 6581
E:\PUBLAW\PUBL003.109
APPS06
PsN: PUBL003
�
